Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. TELA
TELA logo

TELA Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy TELA Bio Inc (TELA) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
0.800
1 Day change
-6.75%
52 Week Range
2.200
Analysis Updated At
2026/06/19
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

TELA Bio Inc is not a good buy at the moment for a beginner investor with a long-term focus and $50,000-$100,000 available for investment. The stock exhibits bearish technical indicators, declining analyst price targets, and lacks positive catalysts or strong financial performance to support a buy decision.

Technical Analysis

The MACD histogram is negative (-0.0114) and expanding downward, indicating a bearish trend. The RSI (37.209) is in the neutral zone but leaning towards oversold territory. Moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is trading near its support level (S1: 0.798), with no clear upward momentum.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
10
Buy
2

Positive Catalysts

  • NULL identified. No significant news, insider or hedge fund activity, or congress trading data to suggest a positive outlook.

Neutral/Negative Catalysts

  • Analysts have significantly lowered price targets, citing reduced growth expectations and missed financial estimates. The stock's bearish technical indicators and lack of trading volume further highlight weak sentiment.

Financial Performance

No financial data available for analysis. However, analysts have noted that Q4 results missed topline estimates, and growth expectations for 2026 have been halved.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts have lowered price targets significantly (e.g., from $5 to $3, $4 to $2, and $1.25 to $1) while maintaining mixed ratings (Outperform, Buy, and Neutral). Analysts highlight reduced growth expectations and the need for the company to prove its ability to meet targets.

Wall Street analysts forecast TELA stock price to rise
4 Analyst Rating
Wall Street analysts forecast TELA stock price to rise
3 Buy
1 Hold
0 Sell
Strong Buy
Current: 0.859
sliders
Low
1.25
Averages
3.31
High
5
Current: 0.859
sliders
Low
1.25
Averages
3.31
High
5
Citizens
David Turkaly
Outperform
to
Outperform
downgrade
$5 -> $3
AI Analysis
2026-03-27
Reason
Citizens
David Turkaly
Price Target
$5 -> $3
AI Analysis
2026-03-27
downgrade
Outperform
to
Outperform
Reason
Citizens analyst David Turkaly lowered the firm's price target on Tela Bio to $3 from $5 and keeps an Outperform rating on the shares. Tela Bio's two main biologic product platforms provide significant benefits to all constituents and a premium growth profile should eventually be achievable, the analyst tells investors in a research note.
Lake Street
Buy
downgrade
$3 -> $2
2026-03-25
Reason
Lake Street
Price Target
$3 -> $2
2026-03-25
downgrade
Buy
Reason
Lake Street lowered the firm's price target on Tela Bio to $2 from $3 and keeps a Buy rating on the shares following an "approximately in line" Q4 and reset of 2026 guidance. The company now guides to 8% top line growth, versus the previous 15% growth expectation introduced with Q3 results, notes the analyst, who says shares "remain in show me territory."
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for TELA
Unlock Now

People Also Watch